ArticleBlood research2026

Venetoclax combined with olverembatinib and prednisone as a frontline therapeutic strategy for Philadelphia chromosome-positive mixed-phenotype acute leukemia.

Xia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.